The Vaccine Trust Problem

The Vaccine Trust Problem

Up next

Classical Music Is in Crisis. Gustavo Dudamel Is Here to Save It.

Music Featured (in order of appearance, all conducted by Gustavo Dudamel):Johann Strauss, Tik-Tak Polka, Polka Schnell, Op. 365, Weiner Philharmoniker (Sony Music Entertainment)Dmitri Shostakovich, Festive Overture, Op. 96, Simón Bolívar Youth Orchestra (Deutsche Grammophon)Gusta ...  Show more

The Intertwined Legacies of Gloria Steinem and Dolly Parton

Gloria Steinem, the feminist icon and co-founder of Ms. magazine, died on Wednesday at her home in Manhattan. Her death came as many were still grieving the loss of another iconic woman: Dolly Parton.On paper, the connections between the two women seem superficial, but for the Ti ...  Show more

Recommended Episodes

How close are we to a vaccine for Covid-19?
The Inquiry

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ...  Show more

The Race for a Vaccine
Chasing Life with Dr. Sanjay Gupta

A vaccine for Covid-19 could come faster than previous vaccines, but it could still be a year or more before one is widely available. CNN's Chief Medical Correspondent Dr. Sanjay Gupta talks to a clinical trial participant and explains why this vaccine search is breaking barriers ...  Show more

Vaccine hesitancy, the next pandemic hurdle
Front Burner

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ...  Show more

The messy vaccine rollout
1 big thing

It's been about a month since the first COVID-19 vaccines were approved in the United States. The goal was to vaccinate 20 million Americans by the end of 2020, but less than a quarter of them have actually received their first dose. Some public health officials are suggesting th ...  Show more